2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Lymphoid
1
Breast
1
Conditions
Frailty
12
Neoplasms
11
Ovarian Neoplasms
5
Lymphoma
5
Lung Neoplasms
4
Breast Neoplasms
4
Prostatic Neoplasms
3
Multiple Myeloma
3
Carcinoma, Non-Small-Cell Lung
3
Lymphoma, Large B-Cell, Diffuse
2
Hematologic Neoplasms
2
Head and Neck Neoplasms
2
Fallopian Tube Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Hepatocellular
2
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Treatment Adherence and Compliance
1
Stomach Neoplasms
1
Solid Neoplasm
1
Sarcopenia
1
Sarcoma
1
Recurrence
1
Prostate Cancer Cured
1
Postoperative Complications
1
Pancreatic Neoplasms
1
Neoplasms, Plasma Cell
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Lymphoma, Non-Hodgkin
1
Interventions
pembrolizumab
5
padeliporfin
5
Nivolumab
5
fludarabine
4
aldesleukin
4
Ipilimumab
4
Cyclophosphamide
4
atezolizumab
3
Sunitinib
3
Specimen Handling
3
Paclitaxel
3
Mitomycin
3
Magnetic Resonance Spectroscopy
3
Gemcitabine
3
Drug Therapy
3
Carboplatin
3
Biopsy
3
Abiraterone Acetate
3
vedolizumab
2
olaparib
2
niraparib
2
motexafin gadolinium
2
enfortumab vedotin
2
darolutamide
2
cabozantinib
2
anlotinib
2
abiraterone
2
Therapeutics
2
Suspensions
2
Surveys and Questionnaires
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Urogenital Neoplasms
×
Geriatric Assessment
×
Clear all
NCT05509751
2026-04-28
SOAR
University of Toronto
Phase NA
Active not recruiting
60 enrolled